Halis Kaan Akturk (H K Akturk, Halis K Akturk)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 58

Top Topics

Systematic Review

Top Venues

Diabetes technology & therapeutics

Journal of diabetes science and technology

Clinical diabetes : a publication of the American Diabetes Association

This page only lists publications with an associated author ORCID identifier.

Publications

Viral N Shah, Lauren G Kanapka, Halis Kaan Akturk, Sarit Polsky, Gregory P Forlenza, Craig Kollman, Roy W Beck, Janet K Snell-Bergeon
Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes technology & therapeutics (2024)
Halis Kaan Akturk, Tadej Battelino, Javier Castañeda, Arcelia Arrieta, Tim van den Heuvel, Ohad Cohen
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes technology & therapeutics 26 (S3) (2024)
Irl B Hirsch, Roy W Beck, Martin Chase Marak, Peter Calhoun, Adham Mottalib, Amna Salhin, Anastasios Manessis, Andrea D Coviello, Anuj Bhargava, Ashley Thorsell, Astrid Atakov Castillo, Bruce W Bode, Camilla Levister, Carol J Levy, Cassandra Donahue, Christian Cordero, Christie Beatson, Christine R Langel, Christopher Jacobson, Corey Kurek, Dana Cruse, David Pickering, Denisa Tamarez, Devin W Steenkamp, Donna Desjardins, Grazia Aleppo, Grenye O'Malley, Halis Kaan Akturk, Jamie Diner, Jesica D Baran, John B Buse, Katrina Ruedy, Kevin Codorniz, Klara R Klein, Kristin N Castorino, Lin Fan Jordan, Mark Kipnes, Mei Mei Church, Osama Hamdy, Philip Raskin, Quang T Nguyen, Tracey D Brown, Scott Lee, Shafaq Rizvi, Suzan Bzdick, Tahereh Ghorbani Rodriguez, Tareq Salah, Thomas Blevins, Yogish C Kudva, Zehra Haider, null null
A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery. Diabetes care 47 (9) (2024)
Matthew P Klein, Halis Kaan Akturk, Janet K Snell-Bergeon, Viral N Shah
Reduced Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Therapy in People With Type 1 Diabetes and Genetic Forms of Obesity. Journal of diabetes science and technology (2024)
Satish K Garg, Halis Kaan Akturk, Gurleen Kaur, Christie Beatson, Janet Snell-Bergeon
Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients with Type 1 Diabetes. Diabetes technology & therapeutics 26 (6) (2024)
Viral N Shah, Lauren G Kanapka, Halis Kaan Akturk, Sarit Polsky, Gregory P Forlenza, Craig Kollman, Roy W Beck, Janet K Snell-Bergeon
Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes technology & therapeutics 26 (4) (2024)
Viral N Shah, Halis Kaan Akturk, Alex Trahan, Nicole Piquette, Alex Wheatcroft, Elain Schertz, Karen Carmello, Lars Mueller, Kirstin White, Larry Fu, Ravid Sassan-Katchalski, Laurel H Messer, Steph Habif, Alex Constantin, Jordan E Pinsker
Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology. Journal of diabetes science and technology (2024)
Tiffany Tian, Rachel E Aaron, Ashley Y DuNova, Johan H Jendle, David C Klonoff, Eda Cengiz, Andjela T Drincic, John C Pickup, Kong Y Chen, Naomi Schwartz, Douglas B Muchmore, Halis Kaan Akturk, Carol J Levy, Signe Schmidt, Riccardo Bellazzi, Alan H B Wu, Elias K Spanakis, Bijan Najafi, James Geoffrey Chase, Jane Jefferie Seley, David C Klonoff
Diabetes Technology Meeting 2023. Journal of diabetes science and technology (2024)
Halis Kaan Akturk
Access to Diabetes Care Should Be a Universal Right for People With Type 1 Diabetes: Lessons Learned From the Norwegian Childhood Diabetes Registry. Diabetes care 47 (7) (2024)
Halis Kaan Akturk, null null
Recent Advances in Diabetes Technology and Activities of the American Diabetes Association Diabetes Technology Interest Group. Clinical diabetes : a publication of the American Diabetes Association 42 (2) (2024)
Halis Kaan Akturk, Kylie Michel, Kasey Couts, Kagan Ege Karakus, William Robinson, Aaron Michels
Routine Blood Glucose Monitoring Does Not Predict Onset of Immune Checkpoint Inhibitor-Induced Type 1 Diabetes. Diabetes care (2024)
Halis Kaan Akturk, null null
Recent Advances in Diabetes Technology and Activities of the American Diabetes Association Diabetes Technology Interest Group. Clinical diabetes : a publication of the American Diabetes Association 42 (2) (2024)
Irl B Hirsch, Roy W Beck, Martin Chase Marak, Peter Calhoun, Adham Mottalib, Amna Salhin, Anastasios Manessis, Andrea D Coviello, Anuj Bhargava, Ashley Thorsell, Astrid Atakov Castillo, Bruce W Bode, Camilla Levister, Carol J Levy, Cassandra Donahue, Christian Cordero, Christie Beatson, Christine R Langel, Christopher Jacobson, Corey Kurek, Dana Cruse, David Pickering, Denisa Tamarez, Devin W Steenkamp, Donna Desjardins, Grazia Aleppo, Grenye O'Malley, Halis Kaan Akturk, Jamie Diner, Jesica D Baran, John B Buse, Katrina Ruedy, Kevin Codorniz, Klara R Klein, Kristin N Castorino, Lin Fan Jordan, Mark Kipnes, Mei Mei Church, Osama Hamdy, Philip Raskin, Quang T Nguyen, Tracey D Brown, Scott Lee, Shafaq Rizvi, Suzan Bzdick, Tahereh Ghorbani Rodriguez, Tareq Salah, Thomas Blevins, Yogish C Kudva, Zehra Haider, null null
A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery. Diabetes care 47 (9) (2024)
Satish K Garg, Halis Kaan Akturk, Gurleen Kaur, Christie Beatson, Janet Snell-Bergeon
Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients with Type 1 Diabetes. Diabetes technology & therapeutics (2024)
Anders L Carlson, Timothy E Graham, Halis Kaan Akturk, David R Liljenquist, Richard M Bergenstal, Becky Sulik, Viral N Shah, Mark Sulik, Peter Zhao, Peter Briggs, Ravid Sassan-Katchalski, Jordan E Pinsker
Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial. Journal of diabetes science and technology (2024)
Halis Kaan Akturk, Tadej Battelino, Javier Castañeda, Arcelia Arrieta, Tim van den Heuvel, Ohad Cohen
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes technology & therapeutics 26 (S3) (2024)
Halis Kaan Akturk
Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes. Diabetes technology & therapeutics (2024)
Halis Kaan Akturk, Tadej Battelino, Javier Castañeda, Arcelia Arrieta, Tim van den Heuvel, Ohad Cohen
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes technology & therapeutics 26 (S3) (2024)
Irl B Hirsch, Roy W Beck, Martin Chase Marak, Peter Calhoun, Adham Mottalib, Amna Salhin, Anastasios Manessis, Andrea D Coviello, Anuj Bhargava, Ashley Thorsell, Astrid Atakov Castillo, Bruce W Bode, Camilla Levister, Carol J Levy, Cassandra Donahue, Christian Cordero, Christie Beatson, Christine R Langel, Christopher Jacobson, Corey Kurek, Dana Cruse, David Pickering, Denisa Tamarez, Devin W Steenkamp, Donna Desjardins, Grazia Aleppo, Grenye O'Malley, Halis Kaan Akturk, Jamie Diner, Jesica D Baran, John B Buse, Katrina Ruedy, Kevin Codorniz, Klara R Klein, Kristin N Castorino, Lin Fan Jordan, Mark Kipnes, Mei Mei Church, Osama Hamdy, Philip Raskin, Quang T Nguyen, Tracey D Brown, Scott Lee, Shafaq Rizvi, Suzan Bzdick, Tahereh Ghorbani Rodriguez, Tareq Salah, Thomas Blevins, Yogish C Kudva, Zehra Haider, null null
A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery. Diabetes care 47 (9) (2024)
Matthew P Klein, Halis Kaan Akturk, Janet K Snell-Bergeon, Viral N Shah
Reduced Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Therapy in People With Type 1 Diabetes and Genetic Forms of Obesity. Journal of diabetes science and technology (2024)
Tiffany Tian, Rachel E Aaron, Ashley Y DuNova, Johan H Jendle, David C Klonoff, Eda Cengiz, Andjela T Drincic, John C Pickup, Kong Y Chen, Naomi Schwartz, Douglas B Muchmore, Halis Kaan Akturk, Carol J Levy, Signe Schmidt, Riccardo Bellazzi, Alan H B Wu, Elias K Spanakis, Bijan Najafi, James Geoffrey Chase, Jane Jefferie Seley, David C Klonoff
Diabetes Technology Meeting 2023. Journal of diabetes science and technology 18 (5) (2024)
Tiffany Tian, Rachel E Aaron, Ashley Y DuNova, Johan H Jendle, David C Klonoff, Eda Cengiz, Andjela T Drincic, John C Pickup, Kong Y Chen, Naomi Schwartz, Douglas B Muchmore, Halis Kaan Akturk, Carol J Levy, Signe Schmidt, Riccardo Bellazzi, Alan H B Wu, Elias K Spanakis, Bijan Najafi, James Geoffrey Chase, Jane Jefferie Seley, David C Klonoff
Diabetes Technology Meeting 2023. Journal of diabetes science and technology 18 (5) (2024)
Irl B Hirsch, Roy W Beck, Martin Chase Marak, Peter Calhoun, Adham Mottalib, Amna Salhin, Anastasios Manessis, Andrea D Coviello, Anuj Bhargava, Ashley Thorsell, Astrid Atakov Castillo, Bruce W Bode, Camilla Levister, Carol J Levy, Cassandra Donahue, Christian Cordero, Christie Beatson, Christine R Langel, Christopher Jacobson, Corey Kurek, Dana Cruse, David Pickering, Denisa Tamarez, Devin W Steenkamp, Donna Desjardins, Grazia Aleppo, Grenye O'Malley, Halis Kaan Akturk, Jamie Diner, Jesica D Baran, John B Buse, Katrina Ruedy, Kevin Codorniz, Klara R Klein, Kristin N Castorino, Lin Fan Jordan, Mark Kipnes, Mei Mei Church, Osama Hamdy, Philip Raskin, Quang T Nguyen, Tracey D Brown, Scott Lee, Shafaq Rizvi, Suzan Bzdick, Tahereh Ghorbani Rodriguez, Tareq Salah, Thomas Blevins, Yogish C Kudva, Zehra Haider, null null
A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery. Diabetes care (2024)
Halis Kaan Akturk, Fran Dong, Janet K Snell-Bergeon, Kagan Ege Karakus, Viral N Shah
Efficacy and Safety of Tirzepatide in Adults With Type 1 Diabetes: A Proof of Concept Observational Study. Journal of diabetes science and technology (2024)
Halis Kaan Akturk
Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes. Diabetes technology & therapeutics 26 (7) (2024)
Matthew P Klein, Halis Kaan Akturk, Janet K Snell-Bergeon, Viral N Shah
Reduced Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Therapy in People With Type 1 Diabetes and Genetic Forms of Obesity. Journal of diabetes science and technology (2024)
Halis Kaan Akturk, Kylie Michel, Kasey Couts, Kagan Ege Karakus, William Robinson, Aaron Michels
Routine Blood Glucose Monitoring Does Not Predict Onset of Immune Checkpoint Inhibitor-Induced Type 1 Diabetes. Diabetes care 47 (3) (2024)
Halis Kaan Akturk, Kylie Michel, Kasey Couts, Kagan Ege Karakus, William Robinson, Aaron Michels
Routine Blood Glucose Monitoring Does Not Predict Onset of Immune Checkpoint Inhibitor-Induced Type 1 Diabetes. Diabetes care 47 (3) (2024)
Viral N Shah, Lauren G Kanapka, Halis Kaan Akturk, Sarit Polsky, Gregory P Forlenza, Craig Kollman, Roy W Beck, Janet K Snell-Bergeon
Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes technology & therapeutics 26 (4) (2024)
Halis Kaan Akturk, Kylie Michel, Kasey Couts, Kagan Ege Karakus, William Robinson, Aaron Michels
Routine Blood Glucose Monitoring Does Not Predict Onset of Immune Checkpoint Inhibitor-Induced Type 1 Diabetes. Diabetes care 47 (3) (2024)
Kağan Ege Karakuş, Viral N Shah, David C Klonoff, Halis Kaan Akturk
Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Halis Kaan Akturk, Casey Sakamoto, Timothy Vigers, Viral N Shah, Laura Pyle
Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use. Journal of diabetes science and technology (2023)
Laurel H Messer, Tim Vigers, Halis Kaan Akturk, Gregory P Forlenza, Kelsey B Huss, Angela J Karami, Emily Malecha, Sean M Oser, Sarit Polsky, Laura Pyle, Viral N Shah, R Paul Wadwa, Tamara K Oser
Increasing Use of Diabetes Devices: What Do Health Care Professionals Need? Clinical diabetes : a publication of the American Diabetes Association 41 (3) (2023)
Guy Todd Alonso, Taylor M Triolo, Halis Kaan Akturk, Meghan E Pauley, Marisa Sobczak, Gregory P Forlenza, Casey Sakamoto, Laura Pyle, Brigitte I Frohnert
Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population. Diabetes care (2023)
Jeremy H Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey, Halis Kaan Akturk, Leslie J Klaff, Julio Rosenstock, Mickie H M Cheng, Bruce W Bode, Edgar D Bautista, Ren Xu, Hai Yan, Dung Thai, Satish K Garg, Samuel Klein
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nature medicine (2023)
Viral N Shah, Halis Kaan Akturk, Timothy Vigers, Laura Pyle, Nicholas S Oliver, David C Klonoff
Relationship Between Daytime Versus Nighttime Continuous Glucose Monitoring Metrics with A1C in Adults with Type 1 Diabetes. Diabetes technology & therapeutics (2022)
Nicole Y Xu, Kevin T Nguyen, Ashley Y DuNova, John C Pickup, Jennifer L Sherr, Hazhir Teymourian, Eda Cengiz, Barry H Ginsberg, Claudio Cobelli, David T Ahn, Riccardo Bellazzi, B Wayne Bequette, Laura Gandrud Pickett, Linda Parks, Elias K Spanakis, Umesh Masharani, Halis Kaan Akturk, John S Melish, Sarah Kim, Gu Eon Kang, David C Klonoff
Diabetes Technology Meeting 2021. Journal of diabetes science and technology 16 (4) (2022)
Satish K Garg, Mark Kipnes, Kristin Castorino, Timothy S Bailey, Halis Kaan Akturk, John B Welsh, Mark P Christiansen, Andrew K Balo, Sue A Brown, Jennifer L Reid, Stayce E Beck
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes technology & therapeutics 24 (6) (2022)
Halis Kaan Akturk, Pau Herrero, Nicholas S Oliver, Haley Wise, Emma Eikermann, Janet Snell-Bergeon, Viral N Shah
Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration. Diabetes technology & therapeutics 24 (10) (2022)
Halis Kaan Akturk, Saketh Rompicherla, Nicole Rioles, Marisa Desimone, Ruth S Weinstock, Sonya J Haw, David C Ziemer, Jane K Dickinson, Shivani Agarwal, Osagie A Ebekozien, Sarit Polsky
Factors Associated With Improved A1C Among Adults With Type 1 Diabetes in the United States. Clinical diabetes : a publication of the American Diabetes Association 41 (1) (2022)
Nicole Y Xu, Kevin T Nguyen, Jan S Krouwer, Halis Kaan Akturk, Viral N Shah, David C Klonoff
Retained Diabetes Devices-A Literature Review. Journal of diabetes science and technology (2022)
Halis Kaan Akturk, Janet Snell-Bergeon, Viral N Shah
Efficacy and Safety of Tandem Control IQ Without User-Initiated Boluses in Adults with Uncontrolled Type 1 Diabetes. Diabetes technology & therapeutics 24 (10) (2022)
Halis Kaan Akturk, Saketh Rompicherla, Nicole Rioles, Marisa Desimone, Ruth S Weinstock, Sonya J Haw, David C Ziemer, Jane K Dickinson, Shivani Agarwal, Osagie A Ebekozien, Sarit Polsky
Factors Associated With Improved A1C Among Adults With Type 1 Diabetes in the United States. Clinical diabetes : a publication of the American Diabetes Association 41 (1) (2022)
Halis Kaan Akturk, Janet Snell-Bergeon, Viral N Shah
Health Care Professionals' Perspectives on Use of Diabetes Technologies for Managing Visually Impaired Patients With Diabetes. Journal of diabetes science and technology (2022)
Anagha Champakanath, Halis Kaan Akturk, G Todd Alonso, Janet K Snell-Bergeon, Viral N Shah
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study. Diabetes care 45 (3) (2022)
Jeremy H Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey, Halis Kaan Akturk, Leslie J Klaff, Julio Rosenstock, Mickie H M Cheng, Bruce W Bode, Edgar D Bautista, Ren Xu, Hai Yan, Dung Thai, Satish K Garg, Samuel Klein
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nature medicine 28 (10) (2022)
Satish K Garg, David Liljenquist, Bruce Bode, Mark P Christiansen, Timothy S Bailey, Ronald L Brazg, Douglas S Denham, Anna R Chang, Halis Kaan Akturk, Andrew Dehennis, Katherine S Tweden, Francine R Kaufman
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study. Diabetes technology & therapeutics (2021)
Halis Kaan Akturk, Janet K Snell-Bergeon, Gregory L Kinney, Anagha Champakanath, Andrew Monte, Viral N Shah
Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes. Diabetes care (2021)
Giada Acciaroli, John B Welsh, Halis Kaan Akturk
Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts. Journal of diabetes science and technology (2021)
Halis Kaan Akturk, Shivani Agarwal, Lilian Hoffecker, Viral N Shah
Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards. Diabetes care 44 (6) (2021)
Cari Berget, Halis Kaan Akturk, Laurel H Messer, Timothy Vigers, Laura Pyle, Janet Snell-Bergeon, Kimberly A Driscoll, Gregory P Forlenza
Real-world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed-loop use. Diabetes, obesity & metabolism 23 (9) (2021)
Viral N Shah, Halis Kaan Akturk, Hal Joseph, Nicole Schneider, Janet K Snell-Bergeon
A randomized controlled trial of transition from insulin pump to multiple daily injections using insulin degludec. Diabetes, obesity & metabolism 23 (8) (2021)
Halis Kaan Akturk, Dominique Giordano, Anagha Champakanath, Scott Brackett, Satish Garg, Janet Snell-Bergeon
Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes. Diabetes, obesity & metabolism 22 (4) (2020)
Gregory L Kinney, Halis Kaan Akturk, Daniel D Taylor, Nicole C Foster, Viral N Shah
Cannabis Use Is Associated With Increased Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Findings From the T1D Exchange Clinic Registry. Diabetes care 43 (1) (2019)
Halis Kaan Akturk, D Kahramangil, A Sarwal, L Hoffecker, M H Murad, Aaron W Michels
Immune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis. Diabetic medicine : a journal of the British Diabetic Association 36 (9) (2019)
Katharine D Barnard-Kelly, Diana Naranjo, Shideh Majidi, Halis Kaan Akturk, Marc Breton, Philippe Courtet, Emilie Olié, Rayhan A Lal, Nicole Johnson, Pr Eric Renard
Suicide and Self-inflicted Injury in Diabetes: A Balancing Act. Journal of diabetes science and technology 14 (6) (2019)
Alessandro Prete, Qi Yan, Khaled Al-Tarrah, Halis Kaan Akturk, Larry J Prokop, Fares Alahdab, Mark A Foster, Janet M Lord, Niki Karavitaki, John A Wass, Mohammad H Murad, Wiebke Arlt, Irina Bancos
The cortisol stress response induced by surgery: A systematic review and meta-analysis. Clinical endocrinology 89 (5) (2018)
Halis Kaan Akturk
Management of Type 1 diabetes should be different from Type 2 diabetes at hospital admission. Diabetic medicine : a journal of the British Diabetic Association 35 (6) (2018)